STRATA Skin Sciences plunges 8% despite new meta-analysis backing its 308 nm excimer laser with up to 85% PASI improvement in plaque psoriasis.
STRATA Skin Sciences, Inc. ( SSKN ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Dolev Rafaeli - President, CEO & Vice-Chairman John Gillings - Principal Financial Officer & Chief Accounting Officer Conference Call Participants Jules Abraham - CorProminence, LLC Destiny Buch - Ladenburg Thalmann & Co. Inc., Research Division Jeremy Pearlman - Maxim Group LLC, Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the STRATA Skin Sciences, Inc. Third Quarter 2025 Financial Results and Corporate Update Conference Call.
STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Dolev Rafaeli - President, CEO & Vice-Chairman John Gillings - Principal Financial Officer & Chief Accounting Officer Conference Call Participants Jeffrey Scott Cohen - Ladenburg Thalmann & Co. Inc., Research Division Jeremy Pearlman - Maxim Group LLC, Research Division Jules Abraham - CorProminence, LLC Operator Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the STRATA Skin Sciences Inc. Second Quarter 2025 Financial Results and Corporate Update Conference Call.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Dolev Rafaeli CEO | XMUN Exchange | US86272A3059 ISIN |
| US Country | 106 Employees | - Last Dividend | 10 Jul 2014 Last Split | 28 Oct 2005 IPO Date |
STRATA Skin Sciences, Inc. is a pioneering medical technology company dedicated to developing, commercializing, and marketing innovative products for treating dermatological conditions. Specifically focusing on the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America, STRATA operates through two main segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company has transitioned from its former identity, MELA Sciences, Inc., embracing its new name, STRATA Skin Sciences, Inc., in January 2016. With its foundation laid in 1989, and headquartering in Horsham, Pennsylvania, STRATA has established a significant footprint in the medical field, aiming to improve patient outcomes and quality of life through its innovative dermatology solutions.
These excimer laser systems are at the forefront of STRATA’s offerings, designed to provide targeted phototherapy treatment for psoriasis, vitiligo, and other skin conditions. By using a specific wavelength of UV light, these lasers can effectively treat affected skin areas without harming the surrounding healthy tissue, offering a non-invasive treatment option with minimal side effects.
Similar to the excimer lasers, the VTRAC lamp systems are developed for the treatment of skin conditions such as psoriasis and vitiligo. These lamp systems utilize a specific form of light therapy to target and treat skin lesions, providing another effective, non-invasive treatment option for patients suffering from these chronic conditions.
Addressing the widespread condition of acne, the TheraClear Acne Therapy System is designed for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. This system combines light therapy with vacuum technology to deeply cleanse and purify the skin, targeting and eliminating acne-causing bacteria, reducing inflammation, and promoting a clearer, healthier-looking complexion.